Cargando...
Statin Use and Risk of Primary Liver Cancer in the Clinical Practice Research Datalink
BACKGROUND: Statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors) are widely prescribed to reduce cholesterol levels. Studies have suggested that statins are associated with reduced risk of liver cancer, but much of the evidence is from regions of the world with high liver cancer inci...
Guardado en:
| Publicado en: | J Natl Cancer Inst |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Oxford University Press
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4351398/ https://ncbi.nlm.nih.gov/pubmed/25722350 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djv009 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|